These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 32120243)
1. Decreased striatal vesicular monoamine transporter 2 (VMAT2) expression in a type 1 diabetic rat model: A longitudinal study using micro-PET/CT. Jiang D; Kong Y; Ren S; Cai H; Zhang Z; Huang Z; Peng F; Hua F; Guan Y; Xie F Nucl Med Biol; 2020; 82-83():89-95. PubMed ID: 32120243 [TBL] [Abstract][Full Text] [Related]
2. PET Imaging of Vesicular Monoamine Transporter 2 in Early Diabetic Retinopathy Using [ Li J; Chen P; Bao Y; Sun Y; He J; Liu X Mol Imaging Biol; 2020 Oct; 22(5):1161-1169. PubMed ID: 31650482 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of Pancreatic VMAT2 Binding with Active and Inactive Enantiomers of [ Naganawa M; Lim K; Nabulsi NB; Lin SF; Labaree D; Ropchan J; Herold KC; Huang Y; Harris P; Ichise M; Cline GW; Carson RE Mol Imaging Biol; 2018 Oct; 20(5):835-845. PubMed ID: 29468404 [TBL] [Abstract][Full Text] [Related]
4. Deuterated Liu F; Choi SR; Zha Z; Ploessl K; Zhu L; Kung HF Nucl Med Biol; 2018 Feb; 57():42-49. PubMed ID: 29306111 [TBL] [Abstract][Full Text] [Related]
5. In vivo imaging of beta-cell mass in rats using 18F-FP-(+)-DTBZ: a potential PET ligand for studying diabetes mellitus. Kung MP; Hou C; Lieberman BP; Oya S; Ponde DE; Blankemeyer E; Skovronsky D; Kilbourn MR; Kung HF J Nucl Med; 2008 Jul; 49(7):1171-6. PubMed ID: 18552132 [TBL] [Abstract][Full Text] [Related]
6. An Efficient Automated Radiosynthesis and Bioactivity Confirmation of VMAT2 Tracer [ Zhao C; Liu C; Tang J; Xu Y; Xie M; Chen Z Mol Imaging Biol; 2020 Apr; 22(2):265-273. PubMed ID: 31165386 [TBL] [Abstract][Full Text] [Related]
7. PET quantification of pancreatic VMAT 2 binding using (+) and (-) enantiomers of [¹⁸F]FP-DTBZ in baboons. Harris PE; Farwell MD; Ichise M Nucl Med Biol; 2013 Jan; 40(1):60-4. PubMed ID: 23102539 [TBL] [Abstract][Full Text] [Related]
8. MicroPET imaging of vesicular monoamine transporter 2 revealed the potentiation of (+)-dihydrotetrabenazine on MPTP-induced degeneration of dopaminergic neurons. Xu Y; Tang J; Liu C; Zhao C; Cao S; Yu H; Chen Z; Xie M Nucl Med Biol; 2021; 96-97():9-18. PubMed ID: 33647803 [TBL] [Abstract][Full Text] [Related]
9. Brain imaging of vesicular monoamine transporter type 2 in healthy aging subjects by 18F-FP-(+)-DTBZ PET. Lin KJ; Weng YH; Hsieh CJ; Lin WY; Wey SP; Kung MP; Yen TC; Lu CS; Hsiao IT PLoS One; 2013; 8(9):e75952. PubMed ID: 24098749 [TBL] [Abstract][Full Text] [Related]
10. Fluoroalkyl derivatives of dihydrotetrabenazine as positron emission tomography imaging agents targeting vesicular monoamine transporters. Goswami R; Ponde DE; Kung MP; Hou C; Kilbourn MR; Kung HF Nucl Med Biol; 2006 Aug; 33(6):685-94. PubMed ID: 16934687 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of pancreatic VMAT2 binding with active and inactive enantiomers of Naganawa M; Lin SF; Lim K; Labaree D; Ropchan J; Harris P; Huang Y; Ichise M; Carson RE; Cline GW Nucl Med Biol; 2016 Dec; 43(12):743-751. PubMed ID: 27673755 [TBL] [Abstract][Full Text] [Related]
12. Study of Vesicular Monoamine Transporter 2 in Myopic Retina Using [ Sun Y; Zhao N; Liu W; Liu M; Ju Z; Li J; Cheng Z; Liu X Mol Imaging Biol; 2018 Oct; 20(5):771-779. PubMed ID: 29520623 [TBL] [Abstract][Full Text] [Related]
13. Cross-sectional and Test-Retest Characterization of PET with [(18)F]FP-(+)-DTBZ for β Cell Mass Estimates in Diabetes. Freeby MJ; Kringas P; Goland RS; Leibel RL; Maffei A; Divgi C; Ichise M; Harris PE Mol Imaging Biol; 2016 Apr; 18(2):292-301. PubMed ID: 26370678 [TBL] [Abstract][Full Text] [Related]
14. Increased Vesicular Monoamine Transporter 2 (VMAT2) and Dopamine Transporter (DAT) Expression in Adolescent Brain Development: A Longitudinal Micro-PET/CT Study in Rodent. Jiang D; Lu X; Li Z; Rydberg N; Zuo C; Peng F; Hua F; Guan Y; Xie F Front Neurosci; 2018; 12():1052. PubMed ID: 30697146 [No Abstract] [Full Text] [Related]
15. Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging. Weng CC; Chen ZA; Chao KT; Ee TW; Lin KJ; Chan MH; Hsiao IT; Yen TC; Kung MP; Hsu CH; Wey SP PLoS One; 2017; 12(3):e0173503. PubMed ID: 28257461 [TBL] [Abstract][Full Text] [Related]
16. Effects of anesthetics on vesicular monoamine transporter type 2 binding to ¹⁸F-FP-(+)-DTBZ: a biodistribution study in rat brain. Chen Z; Tang J; Liu C; Li X; Huang H; Xu X; Yu H Nucl Med Biol; 2016 Jan; 43(1):124-129. PubMed ID: 26526872 [TBL] [Abstract][Full Text] [Related]
17. PET imaging with [ Tang J; Xu Y; Liu C; Fang Y; Cao S; Zhao C; Huang H; Zou M; Chen Z Nucl Med Biol; 2020; 90-91():1-9. PubMed ID: 32861175 [TBL] [Abstract][Full Text] [Related]
18. In vivo imaging of vesicular monoamine transporter 2 in pancreas using an (18)F epoxide derivative of tetrabenazine. Kung HF; Lieberman BP; Zhuang ZP; Oya S; Kung MP; Choi SR; Poessl K; Blankemeyer E; Hou C; Skovronsky D; Kilbourn M Nucl Med Biol; 2008 Nov; 35(8):825-37. PubMed ID: 19026944 [TBL] [Abstract][Full Text] [Related]
19. Assessment of islet specificity of dihydrotetrabenazine radiotracer binding in rat pancreas and human pancreas. Fagerholm V; Mikkola KK; Ishizu T; Arponen E; Kauhanen S; Någren K; Solin O; Nuutila P; Haaparanta M J Nucl Med; 2010 Sep; 51(9):1439-46. PubMed ID: 20720057 [TBL] [Abstract][Full Text] [Related]
20. Pancreatic beta cell mass PET imaging and quantification with [11C]DTBZ and [18F]FP-(+)-DTBZ in rodent models of diabetes. Singhal T; Ding YS; Weinzimmer D; Normandin MD; Labaree D; Ropchan J; Nabulsi N; Lin SF; Skaddan MB; Soeller WC; Huang Y; Carson RE; Treadway JL; Cline GW Mol Imaging Biol; 2011 Oct; 13(5):973-84. PubMed ID: 20824509 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]